Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2012

China Sunergy Co. (CSUN) Executes Sales Contract with Bull PowerTech

Posted on February 15, 2012 by MissionIR

China Sunergy Co., Ltd., a specialized solar cell and module manufacturer, recently announced that it has executed a 50-MW sales contract with Bull PowerTech GmbH. The contract concerns projects in Europe; the shipment is expected to be fully completed by … Continue reading →

Posted in Small Cap News | Leave a comment

Mixed Signals From Key Economic Indicators

Posted on February 14, 2012 by MissionIR

In case you haven’t guessed, one of the most popular activities for the past several months has been the search for a bottom to the seemingly endless global recession. It was easier in the past. A few national indicators would … Continue reading →

Posted in Small Cap News | Leave a comment

Uranium Stocks on the Upswing as Chinese Nuclear Demand Grows

Posted on February 14, 2012 by Mission IR

Uranium stocks have performed well in 2012. The Global X Uranium ETF — the first ETF to track companies involved in uranium mining — is up more than 20 percent this year after collapsing more than 50 percent in 2011 … Continue reading →

Posted in Uranium Energy Corp. UEC | Leave a comment

AdCare Health Systems, Inc. (ADK) Refined Strategy Driving Rapid Growth

Posted on February 14, 2012 by MissionIR

Relatively few of the most successful business are at the place they are because they came up with a totally new concept or industry. In almost every case, a company is successful because it has simply developed a better way … Continue reading →

Posted in AdCare Health Systems Inc. ADK | Leave a comment

VistaGen Therapeutics (VSTA) Selects Top 10 Candidates for Stem Cell Technology-Based Drug Rescue Programs

Posted on February 14, 2012 by MissionIR

VistaGen Therapeutics, Inc., a biotechnology company applying stem cell technology for drug rescue and cell therapy, today announced the identification of its initial Top 10 drug rescue candidates. The company plans to launch two formal drug rescue programs by the … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

GlobalWise Investments, Inc. (GWIV) Finalizes Intellinetics Acquisition

Posted on February 14, 2012 by MissionIR

Today before the opening bell, GlobalWise Investments, Inc. announced the completion of its acquisition of Intellinetics, Inc. (www.Intellinetics.com). Intellinetics is now a wholly owned subsidiary of GlobalWise Investments. Intellinetics is a leading-edge technology company focused on Enterprise Content Management (ECM) … Continue reading →

Posted in GlobalWise Investments Inc. GWIV | Leave a comment

Celsion Corp. (CLSN) Enrolls First Patient in Phase II Study for Colorectal Liver Metastases Treatment

Posted on February 13, 2012 by MissionIR

Leading oncology drug development company Celsion Corp. today announced it has enrolled its first patient in a randomized phase II study of ThermoDox, the company’s lead product candidate. ThermoDox is a heat-activated liposomal encapsulation of doxorubicin that, in combination with … Continue reading →

Posted in Small Cap News | Leave a comment

SunOpta, Inc. (STKL) Announces Opta Minerals’ Acquisition of Babco Industrial

Posted on February 13, 2012 by MissionIR

SunOpta, Inc., a leading global company focused on natural, organic and specialty foods products, today announced that Opta Minerals Inc. has acquired all of the outstanding common shares of Babco Industrial Corp., an industrial processor and supplier of petroleum coke, … Continue reading →

Posted in Small Cap News | Leave a comment

Intellicheck Mobilisa, Inc. (IDN) Secures Contract with Major International Banking Firm

Posted on February 13, 2012 by MissionIR

Intellicheck Mobilisa is engaged in developing and marketing wireless technology and identity systems for various applications, including mobile and handheld access control and security systems for the government, military, and commercial markets. Today, Intellicheck announced they have signed a contract … Continue reading →

Posted in Small Cap News | Leave a comment

FluoroPharma Medical, Inc. (FPMI) Continues to Move New Products Forward

Posted on February 13, 2012 by MissionIR

Turning a good idea into a money making product can be a formidably expensive project, especially when dealing with medical substances to be introduced to the human body. FluoroPharma, developer of medical diagnostic imaging agents for use with PET (positron … Continue reading →

Posted in FluoroPharma Medical Inc. FPMI | Leave a comment